Leaflet SEHCAT 370 KBQ capsules
Indicated for: diagnostic imaging
Route of administration: oral
Substance: selenium (75Se) tauroselcholic acid (contrast agent)
ATC: V09DX01 (Various | Hepatic and reticulo endothelial system | Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals)
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
This medicine is subject to additional monitoring.
Selenium (75Se) tauroselcholic acid is a radioactive compound used in imaging studies to evaluate liver and biliary function. It is administered intravenously and tracked using imaging techniques to assess bile flow and liver function.
The medication is used under the supervision of a nuclear medicine specialist, and the dose is adjusted based on the patient's needs. It is important for patients to inform the doctor of any pre-existing conditions or allergies.
Patients should be aware of potential side effects, such as allergic reactions or discomfort at the injection site. It is important to inform the doctor of any unusual symptoms.
Common side effects include discomfort at the injection site and mild allergic reactions. In rare cases, severe reactions such as hypersensitivity may occur. Patients should be informed of these risks before administration.
General data about SEHCAT 370 KBQ
- Substance: selenium (75Se) tauroselcholic acid
- Date of latest medicines list: 01-09-2023
- Product code: W69711001
- Concentration: 370kBq
- Pharmaceutical form: capsules
- Quantity: 1
- Product type: Original
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.